Global Vascular Endothelial Growth Factor B Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Vascular Endothelial Growth Factor B will have significant change from previous year. According to our (LP Information) latest study, the global Vascular Endothelial Growth Factor B market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vascular Endothelial Growth Factor B market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Vascular Endothelial Growth Factor B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vascular Endothelial Growth Factor B market, reaching US$ million by the year 2028. As for the Europe Vascular Endothelial Growth Factor B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vascular Endothelial Growth Factor B players cover Alteogen Inc, CSL Ltd, Eli Lilly and Company, and Formycon AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor B market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Vascular Endothelial Growth Factor B will have significant change from previous year. According to our (LP Information) latest study, the global Vascular Endothelial Growth Factor B market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vascular Endothelial Growth Factor B market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Vascular Endothelial Growth Factor B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vascular Endothelial Growth Factor B market, reaching US$ million by the year 2028. As for the Europe Vascular Endothelial Growth Factor B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vascular Endothelial Growth Factor B players cover Alteogen Inc, CSL Ltd, Eli Lilly and Company, and Formycon AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor B market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Aflibercept
- Aflibercept Biosimilar
- CSL-346
- Others
- Rectal Cancer
- Retinal Vein Occlusion
- Diabetic Nephropathy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alteogen Inc
- CSL Ltd
- Eli Lilly and Company
- Formycon AG
- Regeneron Pharmaceuticals Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vascular Endothelial Growth Factor B Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vascular Endothelial Growth Factor B by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vascular Endothelial Growth Factor B by Country/Region, 2017, 2022 & 2028
2.2 Vascular Endothelial Growth Factor B Segment by Type
2.2.1 Aflibercept
2.2.2 Aflibercept Biosimilar
2.2.3 CSL-346
2.2.4 Others
2.3 Vascular Endothelial Growth Factor B Sales by Type
2.3.1 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
2.3.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vascular Endothelial Growth Factor B Sale Price by Type (2017-2022)
2.4 Vascular Endothelial Growth Factor B Segment by Application
2.4.1 Rectal Cancer
2.4.2 Retinal Vein Occlusion
2.4.3 Diabetic Nephropathy
2.4.4 Others
2.5 Vascular Endothelial Growth Factor B Sales by Application
2.5.1 Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2017-2022)
2.5.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vascular Endothelial Growth Factor B Sale Price by Application (2017-2022)
3 GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR B BY COMPANY
3.1 Global Vascular Endothelial Growth Factor B Breakdown Data by Company
3.1.1 Global Vascular Endothelial Growth Factor B Annual Sales by Company (2020-2022)
3.1.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2022)
3.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Company (2020-2022)
3.2.1 Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2022)
3.2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2022)
3.3 Global Vascular Endothelial Growth Factor B Sale Price by Company
3.4 Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Endothelial Growth Factor B Product Location Distribution
3.4.2 Players Vascular Endothelial Growth Factor B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VASCULAR ENDOTHELIAL GROWTH FACTOR B BY GEOGRAPHIC REGION
4.1 World Historic Vascular Endothelial Growth Factor B Market Size by Geographic Region (2017-2022)
4.1.1 Global Vascular Endothelial Growth Factor B Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Geographic Region
4.2 World Historic Vascular Endothelial Growth Factor B Market Size by Country/Region (2017-2022)
4.2.1 Global Vascular Endothelial Growth Factor B Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Country/Region
4.3 Americas Vascular Endothelial Growth Factor B Sales Growth
4.4 APAC Vascular Endothelial Growth Factor B Sales Growth
4.5 Europe Vascular Endothelial Growth Factor B Sales Growth
4.6 Middle East & Africa Vascular Endothelial Growth Factor B Sales Growth
5 AMERICAS
5.1 Americas Vascular Endothelial Growth Factor B Sales by Country
5.1.1 Americas Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
5.1.2 Americas Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
5.2 Americas Vascular Endothelial Growth Factor B Sales by Type
5.3 Americas Vascular Endothelial Growth Factor B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Endothelial Growth Factor B Sales by Region
6.1.1 APAC Vascular Endothelial Growth Factor B Sales by Region (2017-2022)
6.1.2 APAC Vascular Endothelial Growth Factor B Revenue by Region (2017-2022)
6.2 APAC Vascular Endothelial Growth Factor B Sales by Type
6.3 APAC Vascular Endothelial Growth Factor B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vascular Endothelial Growth Factor B by Country
7.1.1 Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
7.2 Europe Vascular Endothelial Growth Factor B Sales by Type
7.3 Europe Vascular Endothelial Growth Factor B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vascular Endothelial Growth Factor B by Country
8.1.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
8.2 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type
8.3 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B
10.3 Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
10.4 Industry Chain Structure of Vascular Endothelial Growth Factor B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Endothelial Growth Factor B Distributors
11.3 Vascular Endothelial Growth Factor B Customer
12 WORLD FORECAST REVIEW FOR VASCULAR ENDOTHELIAL GROWTH FACTOR B BY GEOGRAPHIC REGION
12.1 Global Vascular Endothelial Growth Factor B Market Size Forecast by Region
12.1.1 Global Vascular Endothelial Growth Factor B Forecast by Region (2023-2028)
12.1.2 Global Vascular Endothelial Growth Factor B Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vascular Endothelial Growth Factor B Forecast by Type
12.7 Global Vascular Endothelial Growth Factor B Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alteogen Inc
13.1.1 Alteogen Inc Company Information
13.1.2 Alteogen Inc Vascular Endothelial Growth Factor B Product Offered
13.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alteogen Inc Main Business Overview
13.1.5 Alteogen Inc Latest Developments
13.2 CSL Ltd
13.2.1 CSL Ltd Company Information
13.2.2 CSL Ltd Vascular Endothelial Growth Factor B Product Offered
13.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Ltd Main Business Overview
13.2.5 CSL Ltd Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Offered
13.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Formycon AG
13.4.1 Formycon AG Company Information
13.4.2 Formycon AG Vascular Endothelial Growth Factor B Product Offered
13.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Formycon AG Main Business Overview
13.4.5 Formycon AG Latest Developments
13.5 Regeneron Pharmaceuticals Inc
13.5.1 Regeneron Pharmaceuticals Inc Company Information
13.5.2 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Offered
13.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Regeneron Pharmaceuticals Inc Main Business Overview
13.5.5 Regeneron Pharmaceuticals Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vascular Endothelial Growth Factor B Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vascular Endothelial Growth Factor B by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vascular Endothelial Growth Factor B by Country/Region, 2017, 2022 & 2028
2.2 Vascular Endothelial Growth Factor B Segment by Type
2.2.1 Aflibercept
2.2.2 Aflibercept Biosimilar
2.2.3 CSL-346
2.2.4 Others
2.3 Vascular Endothelial Growth Factor B Sales by Type
2.3.1 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
2.3.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vascular Endothelial Growth Factor B Sale Price by Type (2017-2022)
2.4 Vascular Endothelial Growth Factor B Segment by Application
2.4.1 Rectal Cancer
2.4.2 Retinal Vein Occlusion
2.4.3 Diabetic Nephropathy
2.4.4 Others
2.5 Vascular Endothelial Growth Factor B Sales by Application
2.5.1 Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2017-2022)
2.5.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vascular Endothelial Growth Factor B Sale Price by Application (2017-2022)
3 GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR B BY COMPANY
3.1 Global Vascular Endothelial Growth Factor B Breakdown Data by Company
3.1.1 Global Vascular Endothelial Growth Factor B Annual Sales by Company (2020-2022)
3.1.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2022)
3.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Company (2020-2022)
3.2.1 Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2022)
3.2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2022)
3.3 Global Vascular Endothelial Growth Factor B Sale Price by Company
3.4 Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Endothelial Growth Factor B Product Location Distribution
3.4.2 Players Vascular Endothelial Growth Factor B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VASCULAR ENDOTHELIAL GROWTH FACTOR B BY GEOGRAPHIC REGION
4.1 World Historic Vascular Endothelial Growth Factor B Market Size by Geographic Region (2017-2022)
4.1.1 Global Vascular Endothelial Growth Factor B Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Geographic Region
4.2 World Historic Vascular Endothelial Growth Factor B Market Size by Country/Region (2017-2022)
4.2.1 Global Vascular Endothelial Growth Factor B Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vascular Endothelial Growth Factor B Annual Revenue by Country/Region
4.3 Americas Vascular Endothelial Growth Factor B Sales Growth
4.4 APAC Vascular Endothelial Growth Factor B Sales Growth
4.5 Europe Vascular Endothelial Growth Factor B Sales Growth
4.6 Middle East & Africa Vascular Endothelial Growth Factor B Sales Growth
5 AMERICAS
5.1 Americas Vascular Endothelial Growth Factor B Sales by Country
5.1.1 Americas Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
5.1.2 Americas Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
5.2 Americas Vascular Endothelial Growth Factor B Sales by Type
5.3 Americas Vascular Endothelial Growth Factor B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Endothelial Growth Factor B Sales by Region
6.1.1 APAC Vascular Endothelial Growth Factor B Sales by Region (2017-2022)
6.1.2 APAC Vascular Endothelial Growth Factor B Revenue by Region (2017-2022)
6.2 APAC Vascular Endothelial Growth Factor B Sales by Type
6.3 APAC Vascular Endothelial Growth Factor B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vascular Endothelial Growth Factor B by Country
7.1.1 Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
7.2 Europe Vascular Endothelial Growth Factor B Sales by Type
7.3 Europe Vascular Endothelial Growth Factor B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vascular Endothelial Growth Factor B by Country
8.1.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2022)
8.2 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type
8.3 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B
10.3 Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
10.4 Industry Chain Structure of Vascular Endothelial Growth Factor B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Endothelial Growth Factor B Distributors
11.3 Vascular Endothelial Growth Factor B Customer
12 WORLD FORECAST REVIEW FOR VASCULAR ENDOTHELIAL GROWTH FACTOR B BY GEOGRAPHIC REGION
12.1 Global Vascular Endothelial Growth Factor B Market Size Forecast by Region
12.1.1 Global Vascular Endothelial Growth Factor B Forecast by Region (2023-2028)
12.1.2 Global Vascular Endothelial Growth Factor B Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vascular Endothelial Growth Factor B Forecast by Type
12.7 Global Vascular Endothelial Growth Factor B Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alteogen Inc
13.1.1 Alteogen Inc Company Information
13.1.2 Alteogen Inc Vascular Endothelial Growth Factor B Product Offered
13.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alteogen Inc Main Business Overview
13.1.5 Alteogen Inc Latest Developments
13.2 CSL Ltd
13.2.1 CSL Ltd Company Information
13.2.2 CSL Ltd Vascular Endothelial Growth Factor B Product Offered
13.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Ltd Main Business Overview
13.2.5 CSL Ltd Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Offered
13.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Formycon AG
13.4.1 Formycon AG Company Information
13.4.2 Formycon AG Vascular Endothelial Growth Factor B Product Offered
13.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Formycon AG Main Business Overview
13.4.5 Formycon AG Latest Developments
13.5 Regeneron Pharmaceuticals Inc
13.5.1 Regeneron Pharmaceuticals Inc Company Information
13.5.2 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Offered
13.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Regeneron Pharmaceuticals Inc Main Business Overview
13.5.5 Regeneron Pharmaceuticals Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vascular Endothelial Growth Factor B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vascular Endothelial Growth Factor B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aflibercept
Table 4. Major Players of Aflibercept Biosimilar
Table 5. Major Players of CSL-346
Table 6. Major Players of Others
Table 7. Global Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 9. Global Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & ($ million)
Table 10. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2022)
Table 11. Global Vascular Endothelial Growth Factor B Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 14. Global Vascular Endothelial Growth Factor B Revenue by Application (2017-2022)
Table 15. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2022)
Table 16. Global Vascular Endothelial Growth Factor B Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Vascular Endothelial Growth Factor B Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2022)
Table 19. Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2022)
Table 21. Global Vascular Endothelial Growth Factor B Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution and Sales Area
Table 23. Players Vascular Endothelial Growth Factor B Products Offered
Table 24. Vascular Endothelial Growth Factor B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vascular Endothelial Growth Factor B Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Vascular Endothelial Growth Factor B Sales Market Share Geographic Region (2017-2022)
Table 29. Global Vascular Endothelial Growth Factor B Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Vascular Endothelial Growth Factor B Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2017-2022)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 37. Americas Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 39. Americas Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 41. Americas Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 43. APAC Vascular Endothelial Growth Factor B Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
Table 45. APAC Vascular Endothelial Growth Factor B Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Region (2017-2022)
Table 47. APAC Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 49. APAC Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 51. Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 53. Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 55. Europe Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 57. Europe Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor B
Table 68. Key Market Challenges & Risks of Vascular Endothelial Growth Factor B
Table 69. Key Industry Trends of Vascular Endothelial Growth Factor B
Table 70. Vascular Endothelial Growth Factor B Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Vascular Endothelial Growth Factor B Distributors List
Table 73. Vascular Endothelial Growth Factor B Customer List
Table 74. Global Vascular Endothelial Growth Factor B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Vascular Endothelial Growth Factor B Sales Market Forecast by Region
Table 76. Global Vascular Endothelial Growth Factor B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Vascular Endothelial Growth Factor B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Vascular Endothelial Growth Factor B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Vascular Endothelial Growth Factor B Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Application (2023-2028)
Table 94. Alteogen Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 95. Alteogen Inc Vascular Endothelial Growth Factor B Product Offered
Table 96. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Alteogen Inc Main Business
Table 98. Alteogen Inc Latest Developments
Table 99. CSL Ltd Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Ltd Vascular Endothelial Growth Factor B Product Offered
Table 101. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. CSL Ltd Main Business
Table 103. CSL Ltd Latest Developments
Table 104. Eli Lilly and Company Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Offered
Table 106. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Formycon AG Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 110. Formycon AG Vascular Endothelial Growth Factor B Product Offered
Table 111. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Formycon AG Main Business
Table 113. Formycon AG Latest Developments
Table 114. Regeneron Pharmaceuticals Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 115. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Offered
Table 116. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Regeneron Pharmaceuticals Inc Main Business
Table 118. Regeneron Pharmaceuticals Inc Latest Developments
Table 1. Vascular Endothelial Growth Factor B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vascular Endothelial Growth Factor B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aflibercept
Table 4. Major Players of Aflibercept Biosimilar
Table 5. Major Players of CSL-346
Table 6. Major Players of Others
Table 7. Global Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 9. Global Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & ($ million)
Table 10. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2022)
Table 11. Global Vascular Endothelial Growth Factor B Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 14. Global Vascular Endothelial Growth Factor B Revenue by Application (2017-2022)
Table 15. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2022)
Table 16. Global Vascular Endothelial Growth Factor B Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Vascular Endothelial Growth Factor B Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2022)
Table 19. Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2022)
Table 21. Global Vascular Endothelial Growth Factor B Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution and Sales Area
Table 23. Players Vascular Endothelial Growth Factor B Products Offered
Table 24. Vascular Endothelial Growth Factor B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vascular Endothelial Growth Factor B Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Vascular Endothelial Growth Factor B Sales Market Share Geographic Region (2017-2022)
Table 29. Global Vascular Endothelial Growth Factor B Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Vascular Endothelial Growth Factor B Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2017-2022)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 37. Americas Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 39. Americas Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 41. Americas Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 43. APAC Vascular Endothelial Growth Factor B Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
Table 45. APAC Vascular Endothelial Growth Factor B Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Region (2017-2022)
Table 47. APAC Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 49. APAC Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 51. Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 53. Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 55. Europe Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 57. Europe Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor B
Table 68. Key Market Challenges & Risks of Vascular Endothelial Growth Factor B
Table 69. Key Industry Trends of Vascular Endothelial Growth Factor B
Table 70. Vascular Endothelial Growth Factor B Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Vascular Endothelial Growth Factor B Distributors List
Table 73. Vascular Endothelial Growth Factor B Customer List
Table 74. Global Vascular Endothelial Growth Factor B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Vascular Endothelial Growth Factor B Sales Market Forecast by Region
Table 76. Global Vascular Endothelial Growth Factor B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Vascular Endothelial Growth Factor B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Vascular Endothelial Growth Factor B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Vascular Endothelial Growth Factor B Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Application (2023-2028)
Table 94. Alteogen Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 95. Alteogen Inc Vascular Endothelial Growth Factor B Product Offered
Table 96. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Alteogen Inc Main Business
Table 98. Alteogen Inc Latest Developments
Table 99. CSL Ltd Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Ltd Vascular Endothelial Growth Factor B Product Offered
Table 101. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. CSL Ltd Main Business
Table 103. CSL Ltd Latest Developments
Table 104. Eli Lilly and Company Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Offered
Table 106. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Formycon AG Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 110. Formycon AG Vascular Endothelial Growth Factor B Product Offered
Table 111. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Formycon AG Main Business
Table 113. Formycon AG Latest Developments
Table 114. Regeneron Pharmaceuticals Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 115. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Offered
Table 116. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Regeneron Pharmaceuticals Inc Main Business
Table 118. Regeneron Pharmaceuticals Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vascular Endothelial Growth Factor B
Figure 2. Vascular Endothelial Growth Factor B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Endothelial Growth Factor B Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Vascular Endothelial Growth Factor B Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vascular Endothelial Growth Factor B Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aflibercept
Figure 10. Product Picture of Aflibercept Biosimilar
Figure 11. Product Picture of CSL-346
Figure 12. Product Picture of Others
Figure 13. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2021
Figure 14. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2022)
Figure 15. Vascular Endothelial Growth Factor B Consumed in Rectal Cancer
Figure 16. Global Vascular Endothelial Growth Factor B Market: Rectal Cancer (2017-2022) & (K Pcs)
Figure 17. Vascular Endothelial Growth Factor B Consumed in Retinal Vein Occlusion
Figure 18. Global Vascular Endothelial Growth Factor B Market: Retinal Vein Occlusion (2017-2022) & (K Pcs)
Figure 19. Vascular Endothelial Growth Factor B Consumed in Diabetic Nephropathy
Figure 20. Global Vascular Endothelial Growth Factor B Market: Diabetic Nephropathy (2017-2022) & (K Pcs)
Figure 21. Vascular Endothelial Growth Factor B Consumed in Others
Figure 22. Global Vascular Endothelial Growth Factor B Market: Others (2017-2022) & (K Pcs)
Figure 23. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Figure 24. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application in 2021
Figure 25. Vascular Endothelial Growth Factor B Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2021
Figure 27. Global Vascular Endothelial Growth Factor B Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region in 2021
Figure 29. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
Figure 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region in 2021
Figure 31. Americas Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 32. Americas Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 33. APAC Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 34. APAC Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 35. Europe Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 36. Europe Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 39. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 40. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 41. United States Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region in 2021
Figure 46. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Regions in 2021
Figure 47. China Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 54. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 55. Germany Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 62. Egypt Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B in 2021
Figure 68. Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
Figure 69. Industry Chain Structure of Vascular Endothelial Growth Factor B
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of Vascular Endothelial Growth Factor B
Figure 2. Vascular Endothelial Growth Factor B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Endothelial Growth Factor B Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Vascular Endothelial Growth Factor B Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vascular Endothelial Growth Factor B Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aflibercept
Figure 10. Product Picture of Aflibercept Biosimilar
Figure 11. Product Picture of CSL-346
Figure 12. Product Picture of Others
Figure 13. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2021
Figure 14. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2022)
Figure 15. Vascular Endothelial Growth Factor B Consumed in Rectal Cancer
Figure 16. Global Vascular Endothelial Growth Factor B Market: Rectal Cancer (2017-2022) & (K Pcs)
Figure 17. Vascular Endothelial Growth Factor B Consumed in Retinal Vein Occlusion
Figure 18. Global Vascular Endothelial Growth Factor B Market: Retinal Vein Occlusion (2017-2022) & (K Pcs)
Figure 19. Vascular Endothelial Growth Factor B Consumed in Diabetic Nephropathy
Figure 20. Global Vascular Endothelial Growth Factor B Market: Diabetic Nephropathy (2017-2022) & (K Pcs)
Figure 21. Vascular Endothelial Growth Factor B Consumed in Others
Figure 22. Global Vascular Endothelial Growth Factor B Market: Others (2017-2022) & (K Pcs)
Figure 23. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2022)
Figure 24. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application in 2021
Figure 25. Vascular Endothelial Growth Factor B Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2021
Figure 27. Global Vascular Endothelial Growth Factor B Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region in 2021
Figure 29. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
Figure 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region in 2021
Figure 31. Americas Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 32. Americas Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 33. APAC Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 34. APAC Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 35. Europe Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 36. Europe Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Vascular Endothelial Growth Factor B Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Vascular Endothelial Growth Factor B Revenue 2017-2022 ($ Millions)
Figure 39. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 40. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 41. United States Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region in 2021
Figure 46. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Regions in 2021
Figure 47. China Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 54. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 55. Germany Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2021
Figure 62. Egypt Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Vascular Endothelial Growth Factor B Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B in 2021
Figure 68. Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
Figure 69. Industry Chain Structure of Vascular Endothelial Growth Factor B
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
